20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5755 | Aloesin | Tyrosinase | |
Aloesin is a C-glycosylated chromone compound found in aloe (Liliaceae) that inhibits tyrosinase (IC50 = 0.9 mM), an enzyme responsible for catalyzing the first step of the conversion of tyrosine to melanin. | |||
T21806 | HNHA | HDAC | |
HNHA is an inhibitor of HDAC. | |||
T3278 | Piribedil | EU-4200,Trivastan,ET-495,Trivastal | Dopamine Receptor , Histone Methyltransferase , Adrenergic Receptor |
Piribedil (Trivastan) is a dopamine D2 agonist, used in the treatment of Parkinson's disease. | |||
T14980 | CLK-IN-T3 | DYRK , CDK | |
CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity. | |||
T6739 | Zoledronic Acid | CGP-4244,CGP42446A,Zoledronate,CGP 42446,ZOL 446,Zometa | Apoptosis , Rho , Autophagy |
Zoledronic Acid (ZOL 446) is a bisphosphonate. Zoledronic Acid (ZOL 446) is used to prevent skeletal fractures in patients with cancers such as multiple myeloma and prostate cancer. It can also be used to treat hypercalc... | |||
T21299 | Zoledronic acid monohydrate | zoledronate,ZOL 446,CGP 42446,CGP42446A,Zoledronic acid hydrate | Apoptosis , Others , Autophagy |
Zoledronic acid monohydrate (CGP 42446) is a synthetic imidazole bisphosphonate analog with anti-bone-resorption activity. | |||
T10342 | Antitumor agent-2 | Others | |
Antitumor agent-2 has anti-inflammatory and anti-tumor activity and can be used to study cancer. | |||
T26866 | BMS-960 | BMS 960,BMS960 | S1P Receptor |
BMS-960 is an S1P agonist with potential anti-tumour activity for cancer research. | |||
TN1579 | Dihydrocucurbitacin B | 23,24-dihydrocucurbitacin B | IL Receptor , TNF , COX |
Dihydrocucurbitacin B (23,24-dihydrocucurbitacin B) is isolated from the roots of Cayaponia tayuya with anti-cancer activity. | |||
T36123 | 3-Phenyltoxoflavin | ZINC267655,Phenyltoxoflavin | HSP |
3-Phenyltoxoflavin (Phenyltoxoflavin) is an inhibitor of HSP90 (Kd = 585 nM) with anti-cancer activity. | |||
TWS1229 | Aristolone | Aristofone | Others |
Aristolone (Aristofone) has potential anti-cancer activity. | |||
T12150 | N-Methylbenzamide | PDE | |
N-Methylbenzamide is a potent phosphodiesterase 10A (PDE10A) inhibitor,with anti-cancer activity. | |||
T23647 | Zindoxifene | D 16726 | Estrogen/progestogen Receptor |
Zindoxifene (D 16726) is an anti-estrogenic compound with antitumor activity that can be used in studies of breast and prostate cancer. | |||
TMO2685 | 10-Hydroxydecanoic Acid | NSC 15139 | Antibacterial |
10-Hydroxydecanoic Acid (NSC 15139) has antibacterial, anti - cancer and anti - radiation activity. | |||
TN1599 | Eburicoic acid | Eburicoicacid,MFCD00238594,ZINC4655149 | Antioxidant , TNF , NOS , NO Synthase , CCR , Immunology/Inflammation related |
Eburicoic acid (ZINC4655149) exhibits anti-inflammatory and antioxidant activity thereby protecting the liver from CCl4-induced hepatic damage and can be used in studies about anti-liver cancer. | |||
T8432 | ASP4132 | AMPK | |
ASP4132 is an orally active AMPK activator (EC50 : 18 nM), has anti-cancer activity. | |||
T11398 | Ginsenoside Ra3 | Others | |
Ginsenoside Ra3 is a natural product isolated from Panax ginseng, has anti-cancer activity. | |||
T5S0662 | Gelsemine | Gelsemin | Antioxidant |
1. Gelsemine (Gelsemin) has antitumor activity. 2. Gelsemine has anti-oxidative activity. 3. Gelsemine has anti-hyperlipidemic activity. 4. Gelsemine has marked antinociception in inflammatory, neuropathic and bone cance... | |||
TN1222 | 26-Deoxyactein | 27-Deoxyactein,23-epi-26-Deoxyactein | NOS , CDK , NO Synthase |
23-epi-26-Deoxyactein (27-Deoxyactein) has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity of the enzyme. It also has anti-cancer activity, it can in... | |||
T28475 | Pyrazoloacridine | PD-115934,NSC 366140,NSC-366140,PD 115,934,PD 115934 | Apoptosis , Topoisomerase |
Pyrazoloacridine (PD 115934) is a nucleic acid binding agent that inhibits the activity of topo I and II with an IC50 of 1.25 μM in K562 cells. Pyrazoloacridine shows anti-cancer activity. |